Chapter 6: Respiratory System
Legend: 🔵 LQ = Long Question (10-15 marks) | 🟡 SQ = Short Question (5 marks)
Q1. 🔵 LQ - Lung Volumes and Capacities
Lung volumes and capacities describe the amount of air in the lungs at different points of the respiratory cycle.
A. Lung Volumes (4 primary, non-overlapping):
| Volume | Definition | Normal Value |
|---|
| Tidal Volume (TV / VT) | Volume of air inspired or expired in one normal quiet breath | 500 mL |
| Inspiratory Reserve Volume (IRV) | Maximum additional volume that can be inspired above normal tidal inspiration | 3,000 mL |
| Expiratory Reserve Volume (ERV) | Maximum additional volume that can be expired beyond normal tidal expiration | 1,200 mL |
| Residual Volume (RV) | Volume remaining in lungs after maximal forced expiration; cannot be measured by spirometry | 1,200 mL |
B. Lung Capacities (combinations of volumes):
| Capacity | Formula | Normal Value | Clinical Significance |
|---|
| Inspiratory Capacity (IC) | TV + IRV | 3,500 mL | Max breath from resting expiratory level |
| Functional Residual Capacity (FRC) | ERV + RV | 2,400 mL | Volume at end of normal expiration; equilibrium lung volume; ↑ in emphysema, ↓ in fibrosis |
| Vital Capacity (VC) | IRV + TV + ERV | 4,700 mL | Max volume that can be expelled after maximal inspiration; decreases with lung disease, age |
| Total Lung Capacity (TLC) | VC + RV | 5,900 mL | Total volume in lungs at maximal inspiration; ↑ in emphysema, ↓ in restrictive disease |
Note: RV, FRC, and TLC cannot be measured by spirometry alone (need helium dilution or body plethysmograph)
C. Spirometric Measurements:
| Parameter | Definition | Normal | Significance |
|---|
| FVC | Forced Vital Capacity - total air exhaled with max forced effort | ~4.7 L | ↓ in both obstructive and restrictive |
| FEV1 | Volume expired in first second of forced expiration | ~3.5 L (75-80% of FVC) | ↓↓ in obstructive; mildly ↓ in restrictive |
| FEV1/FVC ratio | | > 0.70 (70%) | < 70% = obstructive; normal or ↑ in restrictive |
| PEFR | Peak Expiratory Flow Rate | ~600 L/min in adult males | Used in asthma monitoring |
| FEF 25-75% | Mid-expiratory flow rate | — | Sensitive for early small airway disease |
Pattern Recognition:
| Disease | FVC | FEV1 | FEV1/FVC | TLC | RV |
|---|
| Obstructive (asthma, COPD) | N or ↓ | ↓↓ | ↓ (< 70%) | ↑ | ↑ |
| Restrictive (fibrosis, obesity) | ↓ | ↓ | N or ↑ | ↓ | ↓ or N |
Q2. 🔵 LQ - Mechanics of Breathing, Surfactant, and Compliance
A. Mechanics of Breathing
Quiet Inspiration (active process):
- Diaphragm contracts (descends 1-10 cm) - primary muscle of inspiration (innervated by phrenic nerve C3,4,5)
- External intercostal muscles contract → ribs elevated + outward (bucket-handle movement)
- Thoracic volume increases → intrathoracic pressure falls below atmospheric → air flows IN
- Pleural pressure: -5 cmH2O at rest → -8 cmH2O during inspiration
Quiet Expiration (passive process):
- Diaphragm + intercostals relax
- Elastic recoil of lungs + chest wall drives air out
- No active muscle contraction needed
Forced Expiration (active):
- Internal intercostals contract
- Abdominal muscles contract (rectus abdominis, obliques) → increases intra-abdominal pressure → forces diaphragm upward
Accessory muscles of inspiration:
- Scalene muscles (raise first 2 ribs)
- Sternocleidomastoid (raises sternum)
- Used in severe dyspnoea / respiratory distress
Muscles of forced expiration:
- Internal intercostals
- Abdominal muscles (rectus abdominis, external/internal obliques, transversus)
B. Surfactant
Composition: Dipalmitoyl phosphatidylcholine (DPPC, lecithin) - 70%; other phospholipids + apoproteins (SP-A, SP-B, SP-C, SP-D)
Site of production: Type II pneumocytes (alveolar type II cells); secreted into alveolar surface
Function (LaPlace's Law: P = 2T/r):
- Surfactant reduces surface tension of alveolar fluid
- This is critical because small alveoli (small radius r) would otherwise have very high collapsing pressure
- Without surfactant: small alveoli collapse (atelectasis) + large alveoli overdistend
- Surfactant increases compliance, reduces work of breathing, and stabilises alveoli of different sizes by reducing surface tension more in smaller alveoli (where molecules are closer together)
Clinical significance:
- Neonatal Respiratory Distress Syndrome (NRDS / Hyaline Membrane Disease): Premature infants lack surfactant (adequate surfactant production requires 34-36 weeks gestation; induced by cortisol) → alveolar collapse at birth → severe respiratory distress
- Prevention: Antenatal corticosteroids to mother; postnatal surfactant replacement therapy
- Surfactant also has immune functions via SP-A and SP-D (opsonisation, innate immunity)
C. Compliance
Definition: The change in lung volume produced per unit change in pressure (distending pressure).
C = ΔV / ΔP (mL/cmH2O)
- Normal lung compliance: ~200 mL/cmH2O
Types:
- Static compliance: Measured when no airflow; reflects elastic properties alone
- Dynamic compliance: Measured during airflow; affected by airway resistance
Factors increasing compliance (easier to inflate):
- Emphysema (destruction of elastic tissue)
- Aging
- Surfactant
Factors decreasing compliance (stiffer, harder to inflate):
- Pulmonary fibrosis (increased collagen)
- NRDS (surfactant deficiency)
- Pulmonary oedema
- Atelectasis
Hysteresis: During inflation and deflation, different pressure-volume curves are traced. The area between them represents work done against surface tension and tissue viscosity.
Q3. 🟡 SQ - Dead Space and Alveolar Ventilation
Minute Ventilation (VE) = VT × RR = 500 mL × 12 = 6,000 mL/min
Dead Space:
- Anatomic dead space: Conducting airways (nose → bronchioles, no gas exchange) = 150 mL
- Physiologic dead space: Anatomic + functional (alveoli ventilated but not perfused; e.g., pulmonary embolism); in healthy lungs ≈ anatomic dead space
- Bohr equation for physiologic dead space: VD = VT × (PaCO2 - PECO2) / PaCO2
Alveolar Ventilation (VA) = (VT - VD) × RR = (500 - 150) × 12 = 4,200 mL/min
Only alveolar ventilation participates in gas exchange; dead space ventilation is wasted
Clinical significance: Increased dead space (pulmonary embolism, COPD, positive pressure ventilation) → CO2 retention unless RR or VT compensates
Q4. 🔵 LQ - Gas Exchange and Transport of O2 and CO2
A. Gas Exchange at Alveoli and Tissues
Dalton's Law: Total pressure = sum of partial pressures of each gas
Atmospheric pressure: 760 mmHg; inspired air composition:
- pO2 in atmosphere: 160 mmHg (21% of 760)
- pO2 in alveoli (PAO2): ~100 mmHg (diluted by CO2 + water vapour)
- pCO2 in alveoli (PACO2): ~40 mmHg
Alveolar Gas Equation:
PAO2 = PiO2 - (PaCO2 / RQ) = 150 - (40/0.8) = 100 mmHg
Fick's Law of Diffusion: Rate of diffusion ∝ (surface area × ΔP × solubility) / (thickness × MW)
- Large surface area of alveoli (~70 m2) + thin membrane (0.3-0.5 μm) → rapid diffusion
- CO2 diffuses ~20x faster than O2 (despite lower partial pressure gradient) due to higher solubility
Partial Pressures at Key Sites:
| Gas | Alveolar air | Arterial blood | Venous blood | Tissues |
|---|
| O2 (pO2) | 100 mmHg | 95-100 mmHg | 40 mmHg | 20-40 mmHg |
| CO2 (pCO2) | 40 mmHg | 40 mmHg | 46 mmHg | 45-50 mmHg |
B. Oxygen Transport
1. Dissolved O2: Only 1.5% of total O2 (0.003 mL/100 mL blood per mmHg pO2)
2. Bound to Haemoglobin (HbO2): 98.5% of total O2
- Each gram of Hb carries 1.34 mL O2 when fully saturated
- At Hb 15 g/dL: O2 carrying capacity = 15 × 1.34 = 20.1 mL/100 mL blood
- O2 Content (CaO2) = (Hb × 1.34 × SaO2) + (0.003 × PaO2)
O2-Haemoglobin Dissociation Curve (sigmoid shape):
- Sigmoid due to cooperative binding (allosteric mechanism)
- P50 = partial pressure at which Hb is 50% saturated = 26-27 mmHg
Right shift (↓ O2 affinity = ↑ O2 unloading to tissues) = Bohr Effect:
- ↑ CO2 (↑ H+, acidosis), ↑ temperature, ↑ 2,3-DPG
- Beneficial in exercising tissues (unloads more O2)
Left shift (↑ O2 affinity = ↓ O2 unloading) = Haldane Effect:
- ↓ CO2, alkalosis, ↓ temperature, ↓ 2,3-DPG, HbF (foetal Hb - facilitates O2 transfer from mother to foetus), CO poisoning
C. Carbon Dioxide Transport
CO2 is transported in three forms:
| Form | % of total |
|---|
| Dissolved in plasma | 5-10% |
| Carbaminohaemoglobin (CO2 bound to Hb and other proteins) | 20-25% |
| Bicarbonate (HCO3-) - most important form | 60-70% |
Bicarbonate formation (in RBCs):
CO2 + H2O → H2CO3 → (carbonic anhydrase) → H+ + HCO3-
- H+ buffered by deoxyhaemoglobin (Haldane effect)
- HCO3- exits RBC in exchange for Cl- (chloride shift / Hamburger phenomenon)
At the lungs: All reactions reverse; CO2 expelled
Q5. 🟡 SQ - Ventilation/Perfusion (V/Q) Ratio
Normal V/Q ratio: ~0.8 (VA = 4.2 L/min; Q = 5 L/min)
Regional differences in normal upright lung:
- Apex: V/Q > 0.8 (high) - both ventilation and perfusion are lower but perfusion reduced more; apex relatively over-ventilated
- Base: V/Q < 0.8 (low) - both higher but perfusion increases more than ventilation; base relatively over-perfused
V/Q Mismatch (Causes of Hypoxaemia):
| V/Q State | Description | V/Q ratio | Cause | pO2 | pCO2 |
|---|
| Ideal | Normal match | ~0.8 | — | 100 | 40 |
| Dead space | Ventilated, not perfused | → ∞ | Pulmonary embolism | ~150 (alveolar air) | ~0 |
| High V/Q | Over-ventilated relative to perfusion | > 0.8 | Reduced blood flow | ↑ | ↓ |
| Low V/Q | Under-ventilated relative to perfusion | < 0.8 | Mucus plugging, bronchospasm | ↓ | ↑ |
| Shunt | Perfused, not ventilated | → 0 | Atelectasis, consolidation, AV fistula | Very low | ↑ |
Key difference - V/Q mismatch vs shunt:
- V/Q mismatch: Correctable by giving supplemental O2 (↑ PAO2 corrects hypoxaemia)
- True shunt: NOT correctable by supplemental O2 alone (deoxygenated blood bypasses ventilated alveoli)
Hypoxic vasoconstriction: When PAO2 falls locally → arteriolar vasoconstriction → blood diverted to better-ventilated regions → optimises V/Q matching (opposite of systemic circulation)
Q6. 🔵 LQ - Control of Respiration
Breathing is regulated by respiratory centres in the brainstem that integrate sensory inputs and generate rhythmic motor output.
A. Respiratory Centres (in brainstem):
1. Medullary Respiratory Centres (primary):
- Dorsal Respiratory Group (DRG) - nucleus tractus solitarius: primarily inspiratory neurons; sets basic rhythm; receives afferents from peripheral chemoreceptors + vagus
- Ventral Respiratory Group (VRG) - contains pre-Bötzinger complex (rhythm generator) + Bötzinger complex (expiratory); mainly expiratory but recruits during forced breathing
2. Pontine Centres (modulate medullary rhythm):
- Pontine Respiratory Group (PRG) / Pneumotaxic centre - upper pons: controls rate and depth; inhibits inspiration → smooth cycling; lesion = apneusis (prolonged inspiration)
- Apneustic centre - lower pons: stimulates and prolongs inspiration; normally inhibited by pneumotaxic centre
B. Chemical Control (most important):
1. Central Chemoreceptors (dominant in normal breathing):
- Location: Ventral surface of medulla (separate from respiratory centres)
- Stimulus: ↑ H+ (↓ pH) in CSF - indirectly from ↑ PaCO2 (CO2 crosses BBB, forms H+ in CSF via carbonic anhydrase)
- Response: CO2 ↑ by 1 mmHg → VE increases by ~2 L/min
- NOT directly sensitive to PaO2
2. Peripheral Chemoreceptors:
- Location: Carotid bodies (main; CN IX) + Aortic bodies (CN X)
- Stimulus: ↓ PaO2 (below 60 mmHg - dominant stimulus), ↑ PaCO2, ↓ pH
- Respond rapidly (within seconds) to hypoxaemia
- In chronic hypercapnia (COPD), central receptors desensitise → patient depends on hypoxic drive via peripheral chemoreceptors (danger of giving high-flow O2)
3. Response Summary:
| Stimulus | Receptor | Response |
|---|
| ↑ PaCO2 (↑ H+ in CSF) | Central | ↑ VE (most powerful normal driver) |
| ↓ PaO2 < 60 mmHg | Peripheral | ↑ VE |
| ↓ pH (metabolic acidosis) | Peripheral | ↑ VE (compensatory hyperventilation) |
C. Other Afferent Inputs:
Hering-Breuer Reflex:
- Lung stretch receptors (slowly adapting) in airways → via vagus to DRG → inhibit inspiration when lungs fully inflated
- Prevents over-inflation; important in neonates; minor role in adults at tidal volumes
Juxtapulmonary (J) receptors (C-fibres):
- Located near pulmonary capillaries; stimulated by pulmonary oedema, emboli, chemicals
- Cause rapid shallow breathing, cough, bronchoconstriction
Irritant (rapidly adapting) receptors:
- In airway epithelium; stimulated by dust, smoke, noxious gases → cough, bronchoconstriction
Proprioceptors in muscles and joints:
- Stimulate ventilation during exercise (fast response before blood gas changes occur)
Q7. 🟡 SQ - Hypoxia: Types and Classification
Definition: Hypoxia is inadequate O2 delivery to or utilisation by the tissues.
Classification:
| Type | Mechanism | pO2 (arterial) | O2 Content | O2 Saturation | Examples |
|---|
| Hypoxic (Hypoxaemic) hypoxia | ↓ PaO2 - inadequate O2 loading in lungs | ↓ | ↓ | ↓ | High altitude, V/Q mismatch, hypoventilation, shunt, diffusion impairment |
| Anaemic hypoxia | Normal PaO2 but reduced O2-carrying capacity (↓ Hb or dysfunctional Hb) | Normal | ↓ | Normal | Anaemia, CO poisoning (COHb), methaemoglobinaemia |
| Stagnant (Ischaemic) hypoxia | Normal O2 content but inadequate blood flow to tissues | Normal | Normal | Normal | Heart failure, shock, peripheral arterial disease, local ischaemia |
| Histotoxic hypoxia | Cells cannot utilise O2 despite adequate delivery (mitochondrial blockade) | Normal | Normal | Normal | Cyanide poisoning (blocks cytochrome oxidase), carbon monoxide (high dose) |
Additional types:
- Demand hypoxia: Excessive tissue demand exceeds delivery (e.g., sepsis, hyperthyroidism)
- Affinity hypoxia: Hb has such high O2 affinity it won't release O2 to tissues (carbon monoxide - left shift)
Cyanosis
Definition: Bluish discolouration of skin and mucous membranes due to ≥ 5 g/dL of deoxygenated (reduced) Hb in capillary blood (not a % - absolute amount matters).
Types:
- Central cyanosis: Affects tongue + mucous membranes + periphery; due to arterial hypoxaemia (V/Q mismatch, hypoventilation, shunt, lung disease, high altitude)
- Peripheral cyanosis: Affects extremities only; tongue normal; due to ↑ O2 extraction in cold/slow-moving blood (cold exposure, heart failure, Raynaud's)
Note: Anaemic patients cannot become cyanotic easily (not enough Hb to accumulate 5 g/dL deoxyHb); polycythaemic patients may appear cyanotic at relatively mild hypoxaemia.
Q8. 🔵 LQ - Pulmonary Function Tests and Respiratory Diseases
A. Pulmonary Function Tests (PFTs)
Spirometry:
- FVC, FEV1, FEV1/FVC, PEFR, FEF 25-75% (see Q1 for values)
- Obstructive pattern (FEV1/FVC < 70%): COPD, asthma, bronchiectasis
- Restrictive pattern (FVC ↓, FEV1/FVC normal/↑): pulmonary fibrosis, pleural effusion, chest wall deformity
Flow-volume loop:
- Obstructive: Scooped-out (concave) expiratory limb
- Restrictive: Small loop (reduced volumes), normal shape
Diffusing Capacity for CO (DLCO / TLCO):
- Measures gas transfer across alveolar-capillary membrane
- ↓ DLCO: Emphysema (↓ surface area), pulmonary fibrosis (thickened membrane), pulmonary oedema
- ↑ DLCO: Pulmonary haemorrhage (extra Hb available), polycythaemia, post-exercise
Peak Expiratory Flow Rate (PEFR):
- Cheap, portable monitoring of obstructive disease
- Used for asthma monitoring and severity classification
B. Asthma
Definition: Chronic inflammatory airway disease characterised by reversible airflow obstruction, bronchial hyperresponsiveness, and airway inflammation.
Pathophysiology:
- Trigger (allergen, exercise, cold air, aspirin) → mast cell degranulation → histamine, leukotrienes, prostaglandins
- Bronchospasm: Smooth muscle contraction → airway narrowing
- Mucus hypersecretion → plugging
- Inflammation + oedema → airway wall thickening
- Chronic changes: Airway remodelling (smooth muscle hypertrophy, goblet cell hyperplasia, fibrosis)
Features: Wheeze, breathlessness, chest tightness, cough (especially nocturnal/early morning); diurnal variation
PFTs: Obstructive pattern; reversible with bronchodilator (FEV1 ↑ >12% + >200 mL)
Treatment: Stepwise - SABA (salbutamol) → ICS (budesonide) → LABA + ICS → add-ons; biologics (omalizumab for severe allergic asthma)
C. COPD (Chronic Obstructive Pulmonary Disease)
Definition: Preventable and treatable disease characterised by persistent airflow limitation that is not fully reversible, associated with abnormal inflammatory response to noxious particles/gases.
Two main types:
- Chronic Bronchitis: "Blue bloater" - productive cough >3 months/year for >2 consecutive years; ↑ mucus glands (Reid index > 0.5), mucus hypersecretion; hypoxaemia + hypercapnia; cyanosis + oedema
- Emphysema: "Pink puffer" - permanent destructive enlargement of air spaces distal to terminal bronchioles; ↓ elastic recoil; barrel chest; hyperinflation; pursed-lip breathing; mainly hypoxic but retain CO2 less
Risk factors: Cigarette smoking (#1), air pollution, occupational dust, α1-antitrypsin deficiency (emphysema), recurrent infections
Pathophysiology of Emphysema: Smoking → neutrophils/macrophages → elastase (protease) release → destroys alveolar walls (elastin/collagen) → air trapping + ↓ elastic recoil + ↓ alveolar surface → PFT: ↑ TLC, ↑ RV, ↓ FEV1, ↓ DLCO
Treatment: Smoking cessation (#1), SABA/LAMA bronchodilators, ICS in frequent exacerbations, pulmonary rehabilitation, LTOT (long-term O2 therapy if PaO2 < 55 mmHg), surgery (bullectomy, lung volume reduction)
D. Respiratory Failure
Type 1 (Hypoxaemic): PaO2 < 60 mmHg with normal or ↓ PaCO2
- Mechanism: V/Q mismatch, shunt, diffusion impairment
- Causes: Pneumonia, pulmonary oedema, ARDS, PE, asthma attack
- Treatment: Supplemental O2 (responds well)
Type 2 (Hypercapnic / Ventilatory): PaO2 < 60 mmHg AND PaCO2 > 45 mmHg
- Mechanism: Alveolar hypoventilation (pump failure)
- Causes: COPD exacerbation, respiratory muscle weakness (MG, GBS), CNS depression (opioids), chest wall deformity
- Treatment: Treat cause; NIV (BiPAP); controlled O2 (avoid hypercapnia); intubation if severe
Q9. 🟡 SQ - Oxygen Dissociation Curve (Summary)
The O2-Haemoglobin Dissociation Curve is a sigmoid (S-shaped) curve plotting %Hb saturation against PO2.
Key points on the curve:
- At PaO2 = 100 mmHg (arterial blood): SaO2 = 98% (plateau region - loading in lungs)
- At PO2 = 40 mmHg (mixed venous): SaO2 = 75% (steep region - unloading in tissues)
- At P50 = 26-27 mmHg: SaO2 = 50%
Physiological significance of sigmoid shape:
- Flat upper portion: Loading of O2 in lungs is maintained even if PaO2 drops to ~60 mmHg (SaO2 still 90%) - provides safety margin at altitude/lung disease
- Steep lower portion: Small drop in tissue PO2 → large O2 unloading → tissues can extract more O2 during exercise
Factors causing Right Shift (↓ affinity - more O2 released):
- ↑ CO2, ↑ H+ (↓ pH) = Bohr effect
- ↑ Temperature
- ↑ 2,3-DPG (produced by RBCs in chronic hypoxia, anaemia, high altitude)
Factors causing Left Shift (↑ affinity - less O2 released):
- ↓ CO2, ↓ H+ (↑ pH)
- ↓ Temperature
- ↓ 2,3-DPG
- Foetal Hb (HbF) - binds 2,3-DPG less; allows placental O2 transfer
- Carboxyhaemoglobin (COHb) - CO binds Hb 250x more avidly than O2; also causes left shift; cherry-red colour; treated with 100% O2
Sources: Costanzo Physiology 7th Edition; Murray & Nadel's Textbook of Respiratory Medicine; Tintinalli's Emergency Medicine; Harrison's Principles of Internal Medicine 22nd Edition
Ready to continue with Chapter 7: Renal System whenever you say so!